6505--INO Nitric Oxide
ID: 36C24424Q0007Type: Sources Sought
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF244-NETWORK CONTRACT OFFICE 4 (36C244)PITTSBURGH, PA, 15215, USA

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/c50d095b9be8416daf90a9ec0b77fb72/view
Timeline
    Description

    Sources Sought VETERANS AFFAIRS, DEPARTMENT OF is seeking information and potential qualified sources capable of meeting the minimum requirements and salient characteristics for INOmax®. INOmax is a pharmaceutical drug used for inhalation therapy treatments at the VA Pittsburgh Healthcare System. The contract includes the provision of INOmax, delivery devices, maintenance and calibration items, training, support, and other services. The contract will be for a period of five years. Interested parties should provide company information, size status, and representations, as well as their capabilities and feedback on the salient characteristics. Responses must be submitted by October 13, 2023, via email to sherrie.thompson2@va.gov. This is a request for information only and does not constitute a solicitation.

    Point(s) of Contact
    Sherrie ThompsonContract Specialist
    (215) 823-5800
    sherrie.thompson2@va.gov
    Files
    Title
    Posted
    36C24424Q0007.docx
    Lifecycle
    Title
    Type
    6505--INO Nitric Oxide
    Currently viewing
    Sources Sought
    Similar Opportunities
    6835--Bulk Liquid Oxygen
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking quotes for the procurement of bulk liquid oxygen for the VA Loma Linda Healthcare System, with the contract set aside for Service-Disabled Veteran-Owned Small Businesses. The procurement requires the contractor to provide automatic deliveries of FDA-certified medical-grade oxygen every 7-10 days, maintain the oxygen storage system, and ensure compliance with safety regulations, including emergency services for system failures. This essential service supports patient care at the healthcare facility, with the contract period running from October 1, 2024, to September 30, 2025, and options for four additional one-year extensions. Interested vendors must submit inquiries by September 5, 2024, and attend a site survey on September 10, 2024, with further details available from Contracting Officer Anthony Dela Cruz at anthony.delacruz@va.gov or by phone at 562-766-2284.
    AJ11--Research Support - Medical Gas Supply (5 -year IDIQ)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract for Research Support focused on Medical Gas Supply, specifically for the VA Greater Los Angeles Health Care System. The procurement aims to provide various medical gases, including nitrogen, oxygen, and carbon dioxide, adhering to strict purity and quality standards set by the United States Pharmacopeia and FDA, ensuring compliance with federal regulations. This contract is particularly significant as it supports research activities within a healthcare context while promoting participation from Service-Disabled Veteran-Owned Small Businesses (SDVOSBs). Interested vendors must submit their quotes by September 13, 2024, at 11:59 AM EST, via email to Ms. Millicent Covert at millicent.covert@va.gov, referencing Solicitation 36C24E24Q0092 in the subject line.
    6505--Pylarify(Piflufolastat F18 Injection) for DC VAMC
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified sources to provide Pylarify (Piflufolastat F18 Injection) for the DC Veterans Affairs Medical Center (DC VAMC) in Washington, D.C. The procurement involves the delivery of this radiopharmaceutical to the Nuclear Medicine Section of the Radiology Service, with a base contract period of one year and four optional one-year extensions. This product is critical for diagnostic imaging and treatment in nuclear medicine, and the contractor must ensure compliance with various regulatory standards while providing online ordering capabilities and timely deliveries. Interested parties should submit their responses, including company information and capabilities, to Ryan Singletary at Ryan.Singletary@va.gov by September 16, 2024, at 3:00 PM EST.
    Valsartan
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Valsartan, a drug used for treating high blood pressure and heart failure. The contract will include Valsartan tablets in various strengths and quantities. It will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. Interested parties can contact Catherine Gilbert for more information. The solicitation is projected to be issued in December 2019.
    6835--Bulk Oxygen
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a sole source contract to Matheson Tri-Gas Inc. for the delivery of bulk oxygen and associated services at the Long Beach Healthcare System. This procurement is necessitated by unusual circumstances, specifically the ongoing construction around the facility's main and backup oxygen tanks, which limits access and would create significant operational hardships if removal and replacement were required. The urgency of the situation aligns with Federal Acquisition Regulation provisions that allow for non-competitive solicitation under specific conditions. Interested parties are invited to submit capabilities statements by September 10, 2024, at 7:00 AM PST, and inquiries should be directed to Contracting Officer Anthony Dela Cruz at anthony.delacruz@va.gov or by phone at 562-766-2284.
    Valsartan
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Valsartan, a drug used to treat high blood pressure and heart failure. The contract will include Valsartan tablets in various strengths and quantities. It will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The solicitation will be posted on the DLA Bid Board System and beta.SAM.gov, with a projected solicitation date in June 2021. Interested parties should contact Christopher Newman for more information.
    6505--Zolmitriptan Tablets (VA-25-00006129)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is initiating a Request for Proposal (RFP 36E79724R0028) for the procurement of Zolmitriptan Tablets, aimed at ensuring a reliable supply for various federal health entities, including the Department of Defense and the Bureau of Prisons. The procurement seeks to secure an uninterrupted source of Zolmitriptan, with estimated annual requirements of 28,339 blister packs of 2.5mg tablets and 147,600 blister packs of 5mg tablets, reflecting the critical need for this medication in treating migraines among veterans and other federal beneficiaries. The solicitation is expected to be issued electronically on or around September 5, 2024, with a submission deadline of September 19, 2024; interested vendors should contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov for inquiries and must have an FDA-assigned NDC number to participate.
    DSS Infusion Therapy Manager
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the acquisition of the DSS Infusion Therapy Manager (ITM) software and support, aimed at enhancing patient safety and clinical efficiency within the VA healthcare system. This procurement involves licensing, maintenance, and support for a software solution that integrates with the existing VistA system, facilitating seamless communication between oncologists and pharmacists to minimize medication errors. The contract includes a one-year base period starting September 30, 2024, with four optional renewal years, potentially totaling $34 million in investment. Interested vendors can contact Stephanie Cahill at stephanie.cahill@va.gov or call 303-712-5841 for further details regarding the proposal submission process.
    6505--Prasugrel HCL 5mg and 10mg 30 Count Bottles
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Prasugrel HCL tablets in 5mg and 10mg 30-count bottles, aimed at ensuring a reliable supply for various federal health entities, including the Department of Defense (DoD) and the Bureau of Prisons (BOP). The contract will cover a period of one year with four optional one-year extensions, requiring suppliers to provide products with unique National Drug Codes (NDC) and specific packaging that includes safety caps and designated bottle dimensions. This procurement is critical for maintaining uninterrupted access to essential medications for veterans and other federal health care facilities. Interested vendors should note that the RFP is anticipated to be issued around September 17, 2024, with offers due by October 1, 2024; inquiries should be directed to Contract Specialist Matthew Poulin at Matthew.Poulin@va.gov.
    6505--Levothyroxine Tablets (VA-24-00084562)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to solicit proposals for the procurement of Levothyroxine Sodium Tablets under Request for Proposal (RFP) 36E79724R0020. This procurement aims to secure an uninterrupted supply of these essential medications for various VA facilities, including Consolidated Mail Order Pharmacies, State Veterans Homes, the Indian Health Service, and the Federal Health Care Center. The contract will span one year, with the possibility of four additional pre-priced option periods, reflecting the VA's commitment to meeting the pharmaceutical needs of veterans. Interested suppliers must submit their proposals by September 30, 2024, and can direct inquiries to Contract Specialist Youlanda Duggar at Youlanda.duggar@va.gov or by phone at 708-786-4943.